Most Clinicians, Pharmacists Favor Medical Cannabis Use
Healthcare professionals see the benefits of prescribing cannabis therapies but report significant knowledge gaps in both recreational and medical cannabis.
Neurology
Study Author Q&A: CBT for Patients With Dissociative Seizures
To dig deeper into the study and its importance for a growing field, we spoke with Laura H. Goldstein, PhD, of the Department of Psychology, King’s College London, United Kingdom.
The Role of Precision Medicine in Parkinson Disease
Precision medicine offers a promising therapeutic strategy for patients with Parkinson disease, allowing for tailored treatments which reflect the unique pathophysiology in each patient.
New Report Outlines Current Understanding of Neurological Complications Associated With COVID-19
The ENSG-WFN published a report that details current understanding of the neurologic impacts of COVID-19.
A Review of Pharmacologic Treatment Options for Painful Diabetic Neuropathy
The management of painful diabetic peripheral neuropathy requires the use of effective agents that also may aid in improving sleep and mood.
Air Pollution May Hasten Cognitive Decline in Older Adults
Exposure to air pollution may have adverse effects on cognitive aging and brain health in older adults.
Patients With Newly Diagnosed Multiple Sclerosis More Likely to Have Impaired Cognitive Performance
Compared to the general population, patients with newly diagnosed MS/CIS are more likely to have impaired cognitive function.
Phone-Based Therapy Beneficial for Depression in Parkinson Disease
Telephone-based cognitive behavioral therapy seems to be an effective intervention for depression in Parkinson disease, outperforming treatment-as-usual on all depression, anxiety, and quality-of-life measures.
Efficacy of Isradipine in Early-Stage Parkinson Disease
Researchers assessed the effect of isradipine on clinical progression in previously untreated patients with early-stage PD.
Statin-Associated Risk for Intracerebral Hemorrhage in Patients With Prior Stroke
Treatment with statins is not associated with increased risk for ICH in patients with a history of stroke, and may even decrease the risk for ICH in some of these patients.
-
Loading...
-
Loading...
Next post in Neurology
